Be the answer when patients and professionals seeking balanced information about conditions and therapies ask AI what to choose.
Track recommendations, citations, and competitive framing for accurate, accessible disease and treatment information within strict evidence boundaries. Brand Climb turns every missing or weak answer into an evidence-backed move your team can ship.
Start with prompts like “where can patients find access support?”.
The shortlist forms before patients and professionals seeking balanced information about conditions and therapies reach your site.
Brand Climb shows where accurate, accessible disease and treatment information within strict evidence boundaries enters the answer, what evidence supports it, and what should change next.
Own the question behind “what treatments are available for this condition?”
A regulated product is described without its safety information, in a channel where you have no right of reply.
Make important proof retrievable
Audit approved labeling, safety information, clinical evidence, and current professional guidance; then connect each weak answer to the exact source or page that needs work.
Influence the sources AI already trusts
Measure presence across regulator documents, peer-reviewed studies, medical societies, and approved brand resources, then prioritize the realistic citations that can change the answer.
From a buyer question to the next defensible move.
A repeatable operating loop for patients and professionals seeking balanced information about conditions and therapies.
Map disease and treatment information prompts
Ask “what treatments are available for this condition?” the way a buyer would, and record which brands the engines name, in what order, and on whose evidence.
Trace every material statement to evidence
Indication, off-label discussion and safety information blur together, and models reach for patient forums when the label is not retrievable in a form they can read.
Detect off-label or outdated narratives
Turn approved labeling, safety information, clinical evidence, and current professional guidance into proof an engine can retrieve, then translate “compare mechanisms and important safety considerations” into the single move most likely to change the answer.
Improve access-resource discoverability
Re-ask the same question and compare. A regulated product is described without its safety information, in a channel where you have no right of reply.
AI visibility, quantified
Pharmaceuticals visibility becomes a decision system, not a vanity chart.
Indication, off-label discussion and safety information blur together, and models reach for patient forums when the label is not retrievable in a form they can read. Brand Climb scores recommendation presence, cited evidence and answer accuracy across prompts such as “compare mechanisms and important safety considerations”, and keeps every movement attached to the answer and source it came from — so the correction can be aimed at the thing that actually caused it.
- Decide which answer paths create compliance risk.
- Decide which evidence is being oversimplified.
- Decide which access questions need clearer approved resources.
Quantify the answer, verify approved labeling, safety information, clinical evidence, and current professional guidance, and route the next action with its source trail intact.
Questions teams ask before they operationalize AI visibility.
How Pharmaceuticals teams use Brand Climb.
Keep the evidence shared while giving every role a concrete decision and next move.
Medical affairs
Audit how evidence and clinical context appear in AI answers.
Regulatory
Prioritize unsupported, outdated, or imbalanced statements for review.
Patient services
Make approved access and support pathways easier to find.